Riskpilot← Back to searchSign inGet full accessFREDRIKSTAD MEDFORSK STI
STIActiveOrg 974987163Activities of other membership organisations n.e.c. · NACE 9499Est. 19940 employees
Revenue 2024
NOK 0
EBITDA margin
—
+4% vs 2023
Equity ratio
99.0%
Financial strength
Net profit 2024
NOK -53K
+15% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -79K | +4% |
| Net profit | NOK -53K | +15% |
| Total assets | NOK 791K | -5% |
| Equity | NOK 783K | -6% |
| Employees | 0 | — |
Legal name
FREDRIKSTAD MEDFORSK STI
Org number
974987163
Legal form
Stiftelse
NACE code
9499 · Activities of other membership organisations n.e.c.
Founded
22. juni 1994
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −77 | −65 | −80 | −82 | −79 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −77 | −65 | −80 | −82 | −79 |
| Net financials | 4 | 2 | 6 | 20 | 26 |
| Profit before tax | −73 | −64 | −74 | −63 | −53 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −73 | −64 | −74 | −63 | −53 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 036 | 973 | 899 | 836 | 791 |
| Equity | 1 036 | 973 | 899 | 836 | 783 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 8 |
| Total debt | 0 | 0 | 0 | 0 | 8 |
EBITDA margin
-7924700.0%
This company
15.8%
Market median
-50156429% vs market
20202024
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
-6.8%
This company
18.4%
Market median
-137% vs market
20202024
Net profit margin
-5344900.0%
This company
8.1%
Market median
-65986520% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RD Deputy Member | Deputy Member | 2025 |
| Former (1) | ||
AB Accountant | Accountant | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Chairman | 2014 | |
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FREDRIKSTAD MEDFORSK STI also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnar Dahle | Deputy Member | 0 companies |
| Anita Beate Fredheim | Accountant | 0 companies |
| Gunnar Umbach Hansen | Board of Directors | 0 companies |
| Per Severin Efskind | Chairman | 0 companies |
| Stein Øyvind Jørstad | Board of Directors | 0 companies |
| Terje Bjørnebekk | Board of Directors | 0 companies |